A Phase 2 Trial of AZD1152 in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

John A Radford

    Research output: Contribution to journal › Article › peer-review

    Original languageUndefined
    JournalBlood
    Publication statusPublished - 2014

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    • SDG 3 - Good Health and Well-being

    Other files and links

    Cite this